Clinical Trial Update: Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant [NA]

View source ↗

Summary

A completed clinical trial evaluating a software intervention as adjunctive treatment for ADHD, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Software treatment for ADHD (Aptitude/ALKI software)

Snippet

Sponsor: Akili Interactive Labs, Inc. | Conditions: Attention Deficit Hyperactivity Disorder | NA | Status: COMPLETED | Results posted: 2023-08-09